BioHarvest Sciences Inc. - Common Stock (BHST)
7.1650
+0.1850 (2.65%)
NASDAQ · Last Trade: Jun 10th, 12:48 PM EDT

BioHarvest's olive cell compound, rich in Verbascoside, showed promising results in reducing fat accumulation in liver cells, with a 2026 market launch planned.
Via Benzinga · March 4, 2025

Tate & Lyle and BioHarvest Sciences partner to develop sustainable and affordable plant-based molecules for food and beverage industry.
Via Benzinga · December 11, 2024